Nanopharmaceutics, an evolving field at the intersection of nanotechnology and pharmaceuticals, delves into the application of nanoscale materials for enhanced drug delivery and therapeutic outcomes. By manipulating materials at the nanoscale, researchers aim to overcome traditional pharmaceutical limitations and optimize treatment strategies. Nanopharmaceutics focuses on designing nanocarriers, such as liposomes, nanoparticles, and micelles, to improve drug solubility, stability, and bioavailability.
Incorporating nanopharmaceutics into drug development enhances therapeutic efficacy while minimizing side effects. The field explores innovative approaches like nanocrystals, nanogels, and dendrimers to revolutionize drug formulation. As nanotechnology advances, nanopharmaceutics contributes to the development of novel therapies for various diseases, including cancer, infectious diseases, and neurodegenerative disorders.
Furthermore, nanopharmaceutics plays a pivotal role in diagnostics, employing nanoparticles for imaging and early disease detection. It fosters interdisciplinary collaboration between pharmaceutical sciences, materials science, and nanotechnology, driving continuous innovation in drug design and delivery. The ongoing research in nanopharmaceutics anticipates transformative breakthroughs in drug development, emphasizing precision, efficacy, and patient-centered care. The dynamic synergy between nanotechnology and pharmaceuticals in nanopharmaceutics signifies a paradigm shift in the future of medicine, offering solutions to longstanding challenges and unlocking new frontiers in healthcare.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India